35 reports

  • Market segmentation by type of hormonal therapy
  • Global hormone replacement therapy market by route of administration

Global Hormone Replacement Therapy Market 2015-2019 Covering: An in-depth study of the global hormone replacement therapy market and segmentation by type of hormonal therapy (estrogen replacement therapy and growth hormone replacement therapy), by route of administration (oral, parenteral, and transdermal), and by geography (the Americas,...

  • Hormones
  • Novartis AG
  • Novo Nordisk Group
  • Pfizer Inc.
  • Serono S.A.

The 2019-2024 World Outlook for Hormone Replacement Therapies (HRT) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Hormones
  • OTC
  • World
  • Demand

Global Hormones; their derivatives; steroids Market Business Development Opportunities- Available Tenders, Contracts, values and Companies, 2018- 2023 ##.

  • Hormones
  • OTC
  • World
  • Supply

Hormone replacement therapy Market: Global Industry Analysis, Trends, Market Size & Forecasts to 2023 ##.

  • Hormones
  • OTC
  • Pharmaceutical
  • World
  • Market Size

Menopausal Hot Flashes Market:, Non-Hormonal, Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 ##.

  • Hormones
  • OTC
  • Pharmaceutical
  • World
  • Market Size
  • Hormones Drugs Outlook
  • Hormones Drugs Output (Million Yuan)

China’s demand for Leukemia Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer...

  • Hormones
  • China
  • Supply
  • Tianjin Tianyao Pharmaceutical Co., Ltd
  • Zhejiang Expressway Co., Ltd.

The 2016 World Forecasts of Natural or Synthetic Hormones, Hormone Derivatives, and Other Steriods Used as Hormones Excluding Medicaments Export Supplies ## METHODOLOGY & EXECUTIVE SUMMARY ## ##. ## Our Approach ## ##. ## The World Market: Natural or Synthetic

  • Hormones
  • OTC
  • World
  • Supply

The 2016 World Market Forecasts for Imported Natural or Synthetic Hormones, Hormone Derivatives, and Other Steriods Used as Hormones Excluding Medicaments ## METHODOLOGY & EXECUTIVE SUMMARY ## ##. ## Our Approach ## ##. ## The World Market: Imported Natural or Synthet

  • Hormones
  • World
  • Supply
  • Trade

In what follows, this report begins by summarizing the world market for medicaments containing hormones, their derivatives, and other steriods used as hormones excluding antibiotics and their derivatives exports.

  • Hormone
  • Hormones
  • Therapy
  • World
  • Supply
  • European Others- Recombinant Hormones Market
  • Global Recombinant Hormones Market -Others

In the year 2015, the global market for biopharmaceuticals was valued at USD 176.9 billion. It is estimated at USD 192.2 million for the year 2016 and is projected to reach USD 291 billion by the year 2021. The estimated CAGR during the forecast period (2016-2021) is 8.6%. Current trends in biopharmaceuticals market: On...

  • Hormones
  • World
  • Market Size
  • Merck & Co., Inc.
  • Takeda Pharmaceutical Company Limited
  • Global Prostate Cancer - Forecast for Hormonal Therapy Market (Million US$), 2015 - 2020
  • Global Prostate Cancer - Hormonal Therapy Market (Million US$), 2011 - 2014

Prostate Cancer remains a top priority for health systems around the world as incidence level rises, fueled by growing and aging populations. The main drivers for the prostate cancer market are the increase in the global aging population, innovation in drugs and developments in genomics and proteomics. The prostate cancer market faces some...

  • Chemotherapy
  • Hormones
  • World
  • Astellas Pharma Inc.
  • Medivation, Inc.
  • 91.48% of the Market Share comes from Hormone Replacement Therapy (HRT)
  • Global menopausal hot flashes market 2016 and 2021 (%)

About Menopausal Hot Flashes Menopausal hot flashes are the symptoms of menopause. They refer to feelings of warmth occurring during menopause transition (which includes stages such as premenopause, perimenopause, and postmenopause). Hot flashes cause redness of the skin (known as flushing) and excessive sweating. The menopausal...

  • Hormones
  • World
  • Forecast
  • Allergan plc
  • Pfizer Inc.

Peptide Hormones Market & Pipeline Insight 2015 ##.

  • Hormone
  • Hormones
  • Therapy
  • World
  • Forecast

MARKET ##.

  • Hormones
  • Europe
  • United States
  • World
  • Company Sales
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) TO GENITO URINARY SYSTEM AND SEX HORMONES CLINICAL TRIALS
  • PROPORTION OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) TO GENITO URINARY SYSTEM AND SEX HORMONES CLINICAL TRIALS, G7

Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2017" provides an overview of Focal Segmental Glomerulosclerosis (FSGS) clinical trials scenario. This report provides...

  • Clinical Trial
  • Hormones
  • Therapy
  • World
  • Product Initiative
  • PROPORTION OF NOCTURIA TO GENITO URINARY SYSTEM AND SEX HORMONES CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • PROPORTION OF NOCTURIA TO GENITO URINARY SYSTEM AND SEX HORMONES CLINICAL TRIALS, E7 COUNTRIES (%), 2017*

Nocturia Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Nocturia Global Clinical Trials Review, H2, 2017" provides an overview of Nocturia clinical trials scenario. This report provides top line data relating to the clinical trials on Nocturia. Report...

  • Clinical Trial
  • Hormones
  • Therapy
  • World
  • Product Initiative
  • PROPORTION OF CYSTITIS TO GENITO URINARY SYSTEM AND SEX HORMONES CLINICAL TRIALS, E7 COUNTRIES (%), 2017*
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF CYSTITIS TO GENITO URINARY SYSTEM AND SEX HORMONES CLINICAL TRIALS

Cystitis Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Cystitis Global Clinical Trials Review, H2, 2017" provides an overview of Cystitis clinical trials scenario. This report provides top line data relating to the clinical trials on Cystitis. Report includes an overview of trial...

  • Clinical Trial
  • Genitourinary System Disease
  • Hormones
  • Urology
  • Allergan plc
  • PROPORTION OF MEMBRANOUS GLOMERULONEPHRITIS TO GENITO URINARY SYSTEM AND SEX HORMONES CLINICAL TRIALS, G7 COUNTRIES
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF MEMBRANOUS GLOMERULONEPHRITIS TO GENITO URINARY SYSTEM AND SEX HORMONES CLINICAL TRIALS

Membranous Glomerulonephritis Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Membranous Glomerulonephritis Global Clinical Trials Review, H2, 2017" provides an overview of Membranous Glomerulonephritis clinical trials scenario. This report provides top line data...

  • Autoimmune Disease
  • Hormones
  • Therapy
  • World
  • Product Initiative
  • PROPORTION OF INTERSTITIAL CYSTITIS (PAINFUL BLADDER SYNDROME) TO GENITO URINARY SYSTEM AND SEX HORMONES CLINICAL TRIALS, G7
  • PROPORTION OF INTERSTITIAL CYSTITIS (PAINFUL BLADDER SYNDROME) TO GENITO URINARY SYSTEM AND SEX HORMONES CLINICAL TRIALS, E7

Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H2, 2017" provides an overview of Interstitial Cystitis (Painful Bladder Syndrome)...

  • Autoimmune Disease
  • Clinical Trial
  • Hormones
  • World
  • Product Initiative
  • PROPORTION OF END-STAGE KIDNEY DISEASE (END-STAGE RENAL DISEASE OR ESRD) TO GENITO URINARY SYSTEM AND SEX HORMONES
  • PROPORTION OF END-STAGE KIDNEY DISEASE (END-STAGE RENAL DISEASE OR ESRD) TO GENITO URINARY SYSTEM AND SEX HORMONES

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2017" provides an overview of End-Stage Kidney Disease (End-Stage Renal Disease...

  • Clinical Trial
  • Cytokine
  • Hormones
  • Renal Disease
  • World
  • PROPORTION OF CHRONIC KIDNEY DISEASE (CHRONIC RENAL FAILURE) TO GENITO URINARY SYSTEM AND SEX HORMONES CLINICAL TRIALS, E7
  • PROPORTION OF CHRONIC KIDNEY DISEASE (CHRONIC RENAL FAILURE) TO GENITO URINARY SYSTEM AND SEX HORMONES CLINICAL TRIALS, E7

Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario....

  • Clinical Trial
  • Genitourinary System Disease
  • Hormones
  • Pharmaceutical
  • World
  • Vasomotor Symptoms of Menopause (Hot Flashes) - Drug Profiles
  • ASTRAZENECA PLC

Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H2 2017, provides an overview of the Vasomotor Symptoms of Menopause...

  • Hormones
  • United States
  • World
  • Product Initiative
  • TherapeuticsMD, Inc.
  • Proportion of Renal Stones/Calculi to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%),
  • Clinical Trials by G7 Countries: Proportion of Renal Stones/Calculi to Genito Urinary System And Sex Hormones Clinical Trials

Renal Stones/Calculi Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Renal Stones/Calculi Global Clinical Trials Review, H2, 2016" provides an overview of Renal Stones/Calculi clinical trials scenario. This report provides top line data relating to the clinical trials on Renal Stones/Calculi....

  • Clinical Trial
  • Hormones
  • Pharmaceutical
  • World
  • Product Initiative
  • Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical
  • Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical

Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2016" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario....

  • Clinical Trial
  • Drug Discovery And Development
  • Hormones
  • Pharmaceutical
  • World
  • Clinical Trials by G7 Countries: Proportion of Urinary Retention to Genito Urinary System And Sex Hormones Clinical Trials
  • Proportion of Urinary Retention to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2016*

Urinary Retention Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Urinary Retention Global Clinical Trials Review, H1, 2016" provides an overview of Urinary Retention clinical trials scenario. This report provides top line data relating to the clinical trials on Urinary Retention. Report...

  • Health Services
  • Hormones
  • Urology
  • World
  • Product Initiative
  • Proportion of Interstitial Cystitis (Painful Bladder Syndrome) to Genito Urinary System And Sex Hormones Clinical
  • Proportion of Interstitial Cystitis (Painful Bladder Syndrome) to Genito Urinary System And Sex Hormones Clinical

Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H1, 2016" provides an overview of Interstitial Cystitis (Painful Bladder Syndrome) clinical trials scenario....

  • Autoimmune Disease
  • Hormones
  • Therapy
  • World
  • Product Initiative
  • Clinical Trial profile. 382 Trial Title
  • Target

Menopausal Disorders Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Menopausal Disorders Global Clinical Trials Review, H2, 2017" provides an overview of Menopausal Disorders clinical trials scenario. This report provides top line data relating to the clinical...

  • Clinical Trial
  • Hormone
  • Hormones
  • World
  • Pfizer Inc.
  • Clinical Trials by G7 Countries: Proportion of Nocturnal Enuresis to Genito Urinary System And Sex Hormones Clinical Trials
  • Proportion of Nocturnal Enuresis to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%),

Nocturnal Enuresis Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Nocturnal Enuresis Global Clinical Trials Review, H2, 2015" provides an overview of Nocturnal Enuresis clinical trials scenario. This report provides top line data relating to the clinical trials on Nocturnal Enuresis....

  • Hormone
  • Hormones
  • Therapy
  • World
  • Product Initiative
  • Clinical Trial profile. 30 Trial Title

## ## ## ## ## ## India ## ## ## ## ## ## ## Brazil ## ## ## ## ## ## ## Mexico Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2017 2017 trials are tak

  • Genitourinary System Disease
  • Hormones
  • World
  • Product Initiative
  • Repros Therapeutics Inc.
  • Proportion of Atonic Neurogenic Bladder to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries
  • Clinical Trials by G7 Countries: Proportion of Atonic Neurogenic Bladder to Genito Urinary System And Sex Hormones Clinical Trials

Atonic Neurogenic Bladder Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Atonic Neurogenic Bladder Global Clinical Trials Review, H2, 2015" provides an overview of Atonic Neurogenic Bladder clinical trials scenario. This report provides top line data relating to the clinical trials...

  • Hormones
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative